Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
November 13, 2020Cybin Inc. (NEO: CYBN) At the Forefront of Psychedelic Therapeutic Protocols, DevelopmentPlayBig pharma and life science companies are making big news these days. Thedrug-development space is seeing strong investor interest as thesecompanies make breakthrough advancements that address vast unmet medicalneeds....moreShareView all episodesBy www.stockwave.marketNovember 13, 2020Cybin Inc. (NEO: CYBN) At the Forefront of Psychedelic Therapeutic Protocols, DevelopmentPlayBig pharma and life science companies are making big news these days. Thedrug-development space is seeing strong investor interest as thesecompanies make breakthrough advancements that address vast unmet medicalneeds....more
Big pharma and life science companies are making big news these days. Thedrug-development space is seeing strong investor interest as thesecompanies make breakthrough advancements that address vast unmet medicalneeds.
November 13, 2020Cybin Inc. (NEO: CYBN) At the Forefront of Psychedelic Therapeutic Protocols, DevelopmentPlayBig pharma and life science companies are making big news these days. Thedrug-development space is seeing strong investor interest as thesecompanies make breakthrough advancements that address vast unmet medicalneeds....more
Big pharma and life science companies are making big news these days. Thedrug-development space is seeing strong investor interest as thesecompanies make breakthrough advancements that address vast unmet medicalneeds.